Clot-Busting Drugs in Pregnancy: What the Data Says

Scientists wanted to know if clot-busting drugs are safe during pregnancy. They collected 123 studies. These studies covered 216 pregnant patients. The median age was 31 years. Eighty-five patients had a stroke. The others had blood clots in the legs, lungs, or mechanical heart valves.

The team searched three databases. They used OVID Medline, EMBASE, and Scopus. They only included studies published up to October 2025. They compared the results to what happens in the general pregnant population. They grouped miscarriage and pregnancy termination together. This was done because it was often unclear if the drugs played a role.

The data showed some increased risks. Six of 32 fetal deaths were likely caused by the drugs. Three of those deaths involved stroke patients. The risk of miscarriage was 12.4 percent higher than usual. The risk of stillbirth was 5.9 percent higher. These figures come with a range, so they are not exact. The credible intervals show uncertainty.

For the mothers, the outlook was less concerning. Bleeding in the brain happened at about the same rate as in young non-pregnant patients. The drugs did not appear to add extra harm for the mother. Still, it is difficult to separate the effect of the drug from the effect of the disease. That means people should think critically about what these results really ask us to consider.